Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02422810 · ClinicalTrials.gov registry record
High-Shear Microfluidic Thrombosis Assay
A clinical trial of Coagulation Defects, Other and Unspecified, sponsored by Emory University.
- Completed
- Registry status
- 16
- Enrollment target
- 1
- Study location
NCT02422810 is a study of Coagulation Defects, Other and Unspecified that has completed, run by Emory University. The registered enrollment target is 16 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02422810, a study of Coagulation Defects, Other and Unspecified, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to characterize a new test to assess the rate and time it takes to form a blood clot in people who either do or do not take aspirin.
Conditions Studied
Study Locations (1)
Georgia
- Emory Clinic - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2015-05 |
| Est. Completion | 2015-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02422810
The ClinicalTrials.gov registry entry for NCT02422810 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coagulation Defects, Other and Unspecified appearing as the primary indexed condition, and to 0 interventions.
NCT02422810 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT02422810 about?
NCT02422810 is a clinical study titled "High-Shear Microfluidic Thrombosis Assay". The purpose of this study is to characterize a new test to assess the rate and time it takes to form a blood clot in people who either do or do not take aspirin.
What is the current status of trial NCT02422810?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2015-05. Estimated completion is 2015-10.
What conditions does trial NCT02422810 study?
This clinical trial studies the following conditions: Coagulation Defects, Other and Unspecified.
Who is sponsoring clinical trial NCT02422810?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02422810 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.